Empty Capsules Market Size & Growth Forecast 2026–2035, By Segments (Product, End Use, Therapeutic Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Empty Capsules Market size was estimated at USD 4.08 Billion in 2025 and is projected to grow at a 4% CAGR from 2026 to 2035, reaching USD 6.04 Billion by 2035. The industry revenue for 2026 is assessed at USD 4.22 billion.

• Base Year Value (2025): USD 4.08 Billion
• CAGR (2026-2035): 4%
• Forecast Year Value (2035): USD 6.04 Billion
• Historical Data Period: 2022-2025
• Largest Region: North America
• Forecast Period: 2026-2035

Empty Capsules Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America leads due to mature pharma and nutraceutical manufacturing, steady capsule demand, and compliance-driven procurement supporting repeat high-volume production and supply stability.
  • Asia Pacific is growing at 4.56% CAGR due to expanding manufacturing capacity, rising domestic pharma and supplement output, and increasing export-oriented capsule production demand.

• Segment Momentum:

  • Gelatin accounted for 70.56% of the market in 2025 due to its broad compatibility with pharmaceutical filling processes, consistent performance, and long-standing acceptance in drug and supplement manufacturing.
  • Nutraceutical is the fastest-growing end-use segment as rising interest in preventive health and dietary supplements increases demand for flexible, consumer-friendly capsule formats and new product launches.

• Market Expansion Drivers:

  • Growing geriatric population increasing pharmaceutical capsule consumption for chronic disease management.
  • Rising nutraceutical and cosmeceutical demand accelerating adoption of fast-dissolving capsule formats.
  • Increasing preference for plant-based and specialty capsules supporting product diversification strategies.

• Leading Market Participants:

  Key players in the empty capsules market include Lonza Group AG (Switzerland), ACG Worldwide (India), Qualicaps Co., Ltd. (Japan), Suheung Co., Ltd. (South Korea), CapsCanada Corporation (Canada), Bright Pharma Caps Inc. (United States), HealthCaps India Ltd. (India), Medi-Caps Ltd. (India), Shanxi JC Biological Technology Co., Ltd. (China), Capsugel Belgium NV (Belgium).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 4.08 Billion
  • Projected Market Size: USD 6.04 Billion by 2035
  • Growth Forecasts: 4% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Gelatin (Product) | Pharmaceutical (End Use) | Antibiotic and Antibacterial Drugs (Therapeutic Application)
  • Emerging Opportunity Segment: Non-Gelatin (Product) | Nutraceutical (End Use) | Vitamins and Dietary Supplements (Therapeutic Application)

Market Growth Drivers and Industry Trends

Growing geriatric population increasing pharmaceutical capsule consumption for chronic disease management

As the aging population expands, prescribing volumes for long-term therapies such as cardiovascular, metabolic, pain, and neurological treatments continue to rise, directly increasing demand for the empty capsules market. Capsule dosage forms are widely used where manufacturers need formulation flexibility, efficient filling, and patient-friendly oral delivery, especially for multi-drug regimens associated with chronic care. This steady increase in repeat prescription use supports higher procurement of empty capsules by pharmaceutical producers, while also influencing product mix toward formats that improve swallowability, dosage accuracy, and manufacturing efficiency for chronic disease medicines.

Rising nutraceutical and cosmeceutical demand accelerating adoption of fast-dissolving capsule formats

Consumer demand for ingestible beauty, wellness, and preventive health products is reshaping product development priorities in the empty capsules market, particularly toward fast-dissolving formats that align with convenience and sensory expectations. Nutraceutical and cosmeceutical brands increasingly favor capsule delivery for oils, powders, botanicals, and combination ingredients because it enables clean presentation, rapid consumption, and easier differentiation in crowded retail and e-commerce channels. That shift is influencing market adoption by pushing capsule manufacturers to supply formats tailored to faster disintegration, improved ingredient compatibility, and premium positioning for daily-use wellness products.

Increasing preference for plant-based and specialty capsules supporting product diversification strategies

A clear move toward vegetarian, vegan, and label-conscious consumption is prompting manufacturers to broaden material choices and performance specifications, strengthening market development in the empty capsules market. Pharmaceutical, nutraceutical, and supplement companies are using plant-based and specialty capsules to align formulations with dietary preferences, allergen concerns, religious requirements, and brand positioning, which makes capsule selection a strategic product decision rather than a simple packaging input. This is contributing to market size growth by expanding demand beyond conventional gelatin formats and encouraging suppliers to differentiate through polymer type, release profile, stability characteristics, and suitability for sensitive or moisture-challenging ingredients.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Growing geriatric population increasing pharmaceutical capsule consumption for chronic disease management	1.80%	Moderate	North America, Europe	High	Near Term
Rising nutraceutical and cosmeceutical demand accelerating adoption of fast-dissolving capsule formats	1.50%	Low	Asia Pacific, North America	High	Mid Term
Increasing preference for plant-based and specialty capsules supporting product diversification strategies	1.10%	Moderate	Europe, Asia Pacific	Emerging	Long Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest regional market share in 2025 for the empty capsules market, bolstered by its mature pharmaceutical and nutraceutical manufacturing base and the steady volume requirements of established drug development and supplement brands. Demand remains concentrated in a well-developed production ecosystem where capsule-based delivery is widely used for prescription products, OTC formulations, and dietary supplements, allowing suppliers to benefit from repeat orders, stringent quality expectations, and long-standing buyer relationships. This operating environment helps sustain regional leadership as manufacturers prioritize reliable capsule performance, regulatory compliance, and scalable supply for commercial production.

Asia Pacific is projected to expand at a 4.56% CAGR over the forecast period in the empty capsules market, driven by rising pharmaceutical manufacturing activity and the broadening use of capsule dosage forms across both medicines and health supplements. Growth is being accelerated by the region’s expanding production footprint, where manufacturers are increasing output capacity to serve domestic demand as well as export-oriented supply chains. As drug makers and supplement producers scale operations, capsule procurement rises in parallel, creating practical, volume-led momentum for regional adoption.

Key Country Insights

United States

Formulation Flexibility

The U.S. empty capsules market prioritizes capsule formats compatible with pharmaceutical and nutraceutical product innovation. Manufacturers increasingly seek high-quality gelatin and plant-based capsules that support efficient production, customized formulations, and evolving consumer preferences.

Japan

Premium Capsule Quality

Japan continues advancing the empty capsules market through high-performance capsule materials designed for sensitive formulations and premium healthcare products. Japanese manufacturers value dimensional accuracy, product stability, and dependable manufacturing processes for specialized pharmaceutical applications.

South Korea

Plant-Based Capsule Expansion

South Korea is increasing adoption of plant-based empty capsules to support evolving pharmaceutical and nutraceutical formulation strategies. Manufacturers focus on vegetarian alternatives that deliver reliable filling performance while meeting changing consumer and regulatory expectations.

Germany

Manufacturing Precision

Germany emphasizes precision manufacturing and consistent capsule performance to support demanding pharmaceutical production standards. Companies in Germany prioritize reliable capsule quality, material consistency, and compatibility with automated filling technologies across multiple therapeutic applications.

France

Pharmaceutical Packaging Support

France prioritizes empty capsules that meet stringent pharmaceutical quality requirements while supporting diverse dosage formulations. French manufacturers increasingly adopt advanced capsule technologies that improve production efficiency and product consistency throughout manufacturing operations.

Italy

Nutraceutical Production Alignment

Italy continues strengthening the empty capsules market through growing demand from nutraceutical and dietary supplement manufacturers. Italian producers favor capsule solutions that combine formulation versatility, production efficiency, and compatibility with premium health product development.

Segment Leadership and Growth Trends

  Product Segment Analysis: Gelatin (Largest Segment) vs Non-Gelatin (Fastest-Growing Segment)

Gelatin held the dominant position in the empty capsules market in 2025, accounting for a 70.56% share. Its leadership is underpinned by established use across capsule manufacturing, broad compatibility with standard pharmaceutical filling processes, and dependable performance in high-volume production environments. In the empty capsules market, gelatin remains the preferred option where manufacturers prioritize processing familiarity, consistent shell behavior, and wide acceptance across conventional drug and supplement applications.

Non-gelatin is the fastest-growing product segment in the empty capsules market as demand rises for capsule formats that align with vegetarian, vegan, and ingredient-sensitive product positioning. Its momentum is being reinforced through evolving formulation preferences in health-focused products and by manufacturers seeking alternatives that better fit clean-label and plant-based requirements. Compared with gelatin, non-gelatin capsules are gaining faster traction where end users want broader consumer appeal without relying on animal-derived materials.

End Use Segment Analysis: Pharmaceutical (Largest Segment) vs Nutraceutical (Fastest-Growing Segment)

By end use, pharmaceutical represented the largest share of the empty capsules market in 2025. This leadership is tied to the sector’s steady need for reliable oral dosage delivery systems, where capsule consistency, dosing precision, and compatibility with regulated production workflows remain essential. The empty capsules market continues to benefit from pharmaceutical demand because capsules are deeply integrated into routine drug manufacturing and reinforced through established development and filling infrastructure.

Nutraceutical is the fastest-growing end-use segment in the empty capsules market, driven by expanding consumer interest in preventive health, dietary supplements, and wellness-focused formulations. Growth is accelerating as supplement producers introduce a wider variety of encapsulated products that require flexible, consumer-friendly dosage formats. Relative to pharmaceutical demand, the nutraceutical segment is gaining momentum faster because product innovation cycles are often quicker and consumer preferences are directly shaping capsule-based supplement launches.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Product	Gelatin, Non-Gelatin	Gelatin	Non-Gelatin
End Use	Pharmaceutical, Nutraceutical, Cosmeceutical, Research Laboratories	Pharmaceutical	Nutraceutical
Therapeutic Application	Antibiotic and Antibacterial Drugs, Vitamins and Dietary Supplements, Antacid and Antiflatulent Preparations, Antianemic Preparations (Hematenic Preparations), Anti-Inflammatory Drugs, Cardiovascular Therapy Drugs, Cough and Cold Preparations, Others	Antibiotic and Antibacterial Drugs	Vitamins and Dietary Supplements

Competitive Landscape and Market Positioning

Top players in the empty capsules market:

1. Lonza Group AG (Switzerland)

2. ACG Worldwide (India)

3. Qualicaps Co. Ltd. (Japan)

4. Suheung Co. Ltd. (South Korea)

5. CapsCanada Corporation (Canada)

6. Bright Pharma Caps Inc. (United States)

7. HealthCaps India Ltd. (India)

8. Medi-Caps Ltd. (India)

9. Shanxi JC Biological Technology Co. Ltd. (China)

10. Capsugel Belgium NV (Belgium)

The empty capsules market is experiencing strong innovation focused on improving formulation compatibility and manufacturing efficiency. Manufacturers are introducing plant-based, delayed-release, and customized capsule solutions to address changing pharmaceutical and nutraceutical requirements. Automation in capsule production and advancements in encapsulation technologies are also supporting higher productivity and quality consistency across the market.

Industry Development/News

Company Name	Date	Key Development
ACG	Oct-25	ACG announced a USD 200 million investment to establish its first empty-capsule manufacturing plant in the United States. This facility is designed to enhance domestic supply chain security and localize production to meet growing regional demand for high-quality capsule solutions.
PSK Pharma	Nov-25	PSK Pharma commenced commercial production of empty hard gelatin capsules under its proprietary PHARMCAPS brand. This entry marks a strategic expansion of its operational footprint into the specialized pharmaceutical packaging segment, strengthening its vertical integration capabilities.
EMBOCAPS	Oct-24	EMBOCAPS introduced the EMBOCAPS FLEX, a dual-size capsule technology featuring a versatile locking system. This innovation allows manufacturers to switch between size #00 and #00E specifications on existing machinery, optimizing production flexibility and accommodating varied fill volumes or material densities in pharmaceutical formulations.
VANTAGE NUTRITION	Mar-23	VANTAGE NUTRITION, an ACG company, acquired U.S.-based ComboCap, Inc. and South Africa-based BioCap. The strategic acquisition aims to accelerate the global deployment of advanced encapsulation technologies and expand the company’s geographic manufacturing footprint in North America and emerging international markets.